Literature DB >> 17400453

Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.

Koushi Hidaka1, Tooru Kimura, Yumi Tsuchiya, Mami Kamiya, Adam J Ruben, Ernesto Freire, Yoshio Hayashi, Yoshiaki Kiso.   

Abstract

Based on a highly potent allophenylnorstatine-containing inhibitor, KNI-10006, against the plasmepsins of Plasmodium falciparum, we synthesized a series of tripeptide-type compounds with various N-terminal moieties and evaluated their inhibitory activities against plasmepsin II. Certain phenylacetyl derivatives exhibited extremely high affinity with K(i) values of less than 0.1n M suggesting successful hydrophobic interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400453     DOI: 10.1016/j.bmcl.2007.03.052

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights.

Authors:  Vandana Mishra; Ishan Rathore; Anagha Arekar; Lakshmi Kavitha Sthanam; Huogen Xiao; Yoshiaki Kiso; Shamik Sen; Swati Patankar; Alla Gustchina; Koushi Hidaka; Alexander Wlodawer; Rickey Y Yada; Prasenjit Bhaumik
Journal:  FEBS J       Date:  2018-07-07       Impact factor: 5.542

2.  Structural insights into the activation and inhibition of histo-aspartic protease from Plasmodium falciparum.

Authors:  Prasenjit Bhaumik; Huogen Xiao; Koushi Hidaka; Alla Gustchina; Yoshiaki Kiso; Rickey Y Yada; Alexander Wlodawer
Journal:  Biochemistry       Date:  2011-09-26       Impact factor: 3.162

3.  The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active.

Authors:  Huogen Xiao; Brian C Bryksa; Prasenjit Bhaumik; Alla Gustchina; Yoshiaki Kiso; Shao Q Yao; Alexander Wlodawer; Rickey Y Yada
Journal:  Mol Biochem Parasitol       Date:  2014-10-25       Impact factor: 1.759

4.  Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

Authors:  Koushi Hidaka; Tooru Kimura; Adam J Ruben; Tsuyoshi Uemura; Mami Kamiya; Aiko Kiso; Tetsuya Okamoto; Yumi Tsuchiya; Yoshio Hayashi; Ernesto Freire; Yoshiaki Kiso
Journal:  Bioorg Med Chem       Date:  2008-10-10       Impact factor: 3.641

5.  Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.

Authors:  Alejandro Gil L; Pedro A Valiente; Pedro G Pascutti; Tirso Pons
Journal:  J Trop Med       Date:  2011-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.